Profiel
David R.
Jones worked as the Chief Medical Officer at Diffusion Pharmaceuticals LLC and RestorGenex Corp.
He was also a Professor at the University of Virginia from 2007 to 2013.
Later, he worked as the Chief Medical Officer at Diffusion Pharmaceuticals, Inc. from 2012 to 2019.
Jones received his undergraduate and doctorate degrees from West Virginia University.
Eerdere bekende functies van David R. Jones
Bedrijven | Functie | Einde |
---|---|---|
University of Virginia | Corporate Officer/Principal | 01-01-2013 |
DIFFUSION PHARMA | Hoofd Techniek/Wetenschap/O&O | 01-01-2019 |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Hoofd Techniek/Wetenschap/O&O | - |
Diffusion Pharmaceuticals LLC
Diffusion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van David R. Jones
West Virginia University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Diffusion Pharmaceuticals LLC
Diffusion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals LLC develops and manufactures pharmaceutical products. The firm develops trans sodium crocetinate for use in cancers types in which tumor hypoxia (oxygen deprivation) is known to diminish the effectiveness of current treatments. The company was founded by Matthew W. Hantzmon, John L. Gainer, and David G. Kalergis in February 2001 and is headquartered in Charlottesville, VA. | Health Technology |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Health Technology |
Diffusion Pharmaceuticals, Inc.
Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |